Logo image of SING

SINGLEPOINT INC (SING) Stock Fundamental Analysis

NYSEARCA:SING - NYSE Arca - US82932V4095 - Common Stock - Currency: USD

0.2113  -0.17 (-44.25%)

After market: 0.1612 -0.05 (-23.71%)

Fundamental Rating

2

SING gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 98 industry peers in the Electrical Equipment industry. SING has a bad profitability rating. Also its financial health evaluation is rather negative. SING has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

SING had negative earnings in the past year.
In the past year SING has reported a negative cash flow from operations.
In the past 5 years SING always reported negative net income.
In the past 5 years SING always reported negative operating cash flow.
SING Yearly Net Income VS EBIT VS OCF VS FCFSING Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 -10M -20M -30M -40M -50M

1.2 Ratios

SING's Return On Assets of 16.96% is amongst the best of the industry. SING outperforms 97.78% of its industry peers.
Industry RankSector Rank
ROA 16.96%
ROE N/A
ROIC N/A
ROA(3y)-137.17%
ROA(5y)-1266.54%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SING Yearly ROA, ROE, ROICSING Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 0 5K -5K -10K

1.3 Margins

The Profit Margin of SING (10.95%) is better than 88.89% of its industry peers.
The Gross Margin of SING (29.80%) is better than 70.00% of its industry peers.
In the last couple of years the Gross Margin of SING has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 10.95%
GM 29.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.68%
GM growth 5Y22.07%
SING Yearly Profit, Operating, Gross MarginsSING Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 0 -5K -10K -15K -20K

More info and screens

0

2. Health

2.1 Basic Checks

SING does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SING has more shares outstanding
SING has a better debt/assets ratio than last year.
SING Yearly Shares OutstandingSING Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M
SING Yearly Total Debt VS Total AssetsSING Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of -7.63, we must say that SING is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of SING (-7.63) is worse than 86.67% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.63
ROIC/WACCN/A
WACC2.34%
SING Yearly LT Debt VS Equity VS FCFSING Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 0 -2M -4M

2.3 Liquidity

A Current Ratio of 0.28 indicates that SING may have some problems paying its short term obligations.
The Current ratio of SING (0.28) is worse than 93.33% of its industry peers.
A Quick Ratio of 0.16 indicates that SING may have some problems paying its short term obligations.
SING's Quick ratio of 0.16 is on the low side compared to the rest of the industry. SING is outperformed by 94.44% of its industry peers.
Industry RankSector Rank
Current Ratio 0.28
Quick Ratio 0.16
SING Yearly Current Assets VS Current LiabilitesSING Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for SING have decreased strongly by -1853.61% in the last year.
The Revenue has grown by 121.70% in the past year. This is a very strong growth!
SING shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 142.53% yearly.
EPS 1Y (TTM)-1853.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.18%
Revenue 1Y (TTM)121.7%
Revenue growth 3Y86.77%
Revenue growth 5Y142.53%
Sales Q2Q%5.02%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SING Yearly Revenue VS EstimatesSING Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SING. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SING Price Earnings VS Forward Price EarningsSING Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SING Per share dataSING EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100 -100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SING!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SINGLEPOINT INC

NYSEARCA:SING (9/10/2024, 8:04:00 PM)

After market: 0.1612 -0.05 (-23.71%)

0.2113

-0.17 (-44.25%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)09-12 2024-09-12
Earnings (Next)11-12 2024-11-12
Inst Owners48.73%
Inst Owner Change-78.94%
Ins Owners52883.63%
Ins Owner Change0%
Market Cap50.71K
AnalystsN/A
Price TargetN/A
Short Float %3.61%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-141.19
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-6.86
FCFYN/A
OCF(TTM)-6.86
OCFYN/A
SpS124.56
BVpS-37.35
TBVpS-79.8
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 16.96%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 10.95%
GM 29.8%
FCFM N/A
ROA(3y)-137.17%
ROA(5y)-1266.54%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.68%
GM growth 5Y22.07%
F-Score5
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.28
Quick Ratio 0.16
Altman-Z -7.63
F-Score5
WACC2.34%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1853.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.18%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)121.7%
Revenue growth 3Y86.77%
Revenue growth 5Y142.53%
Sales Q2Q%5.02%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y61.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y60.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y60.88%
OCF growth 3YN/A
OCF growth 5YN/A